Login

Categories

Consumer Corporate Energy Entertainment Experts Financials Healthcare Industrial Law Markets Media Mining Private Equity Real Estates Sports Startups Technology Venture Capital

Recent Videos

00:00:00
Dr. Tim Rodell, M.D., CEO and Director at Aethlon Medical, Inc
00:00:00
AirXpanders Inc.(ASX:AXP) sales and product update - Scott Dodson, CEO,AirXpanders Inc
00:00:00
4D Pharma raises $40 million - Duncan Peyton, CEO, 4D Pharma
00:00:00
4D Pharma finds success for its Parkinson’s treatment - Duncan Peyton, CEO, 4D Pharma
00:00:00
4D pharma gets green light for phase I clinical trial of Parkinson's disease - Duncan Peyton, CEO, 4D Pharma
00:00:00
4D Pharma hopes to expand drug success to other areas - Duncan Peyton, CEO, 4D Pharma
00:00:00
4d pharma reveals 'phenomenal results' from early stage cancer trial - Duncan Peyton, CEO, 4D Pharma
00:00:00
Interview with Alan Clarke, CEO Abano Healthcare Limited
00:00:00
Dr. Hartmut Ehrlich, CEO, Abivax
00:00:00
EnterNext welcomes Abivax on Euronext in Paris - Dr. Hartmut Ehrlich, CEO, Abivax
00:00:00
Abivax seeks partners - Dr. Hartmut Ehrlich, CEO, Abivax
00:00:00
John Burt, chief executive of Abzena PLC
00:00:00
Per Persson, CEO of Acarix
00:00:00
Timothy Morris - CFO, Head of Business Development, AcelRx Pharmaceuticals Inc
00:00:00
Ed Gudaitis, President and CEO, Acerus Pharmaceuticals Corporation
00:00:00
Ed Gudaitis, President and CEO, Acerus Pharmaceuticals Corporation
00:00:00
Ed Gudaitis, President and CEO, Acerus Pharmaceuticals Corporation
00:00:00
AdAlta delivers positive Phase I Extension Study results - Tim Oldham, MD, Adalta Ltd
00:00:00
AdAlta Phase I Extension Study Results - Tim Oldham, MD, Adalta Ltd
00:00:00
Addex Therapeutics CEO Tim Dyer: There is a $4-bil market opportunity in dyskinesia

© 2017 - Neuhu+